Wikipedia
Fabre-Kramer
Fabre-Kramer Pharmaceuticals is a pharmaceutical company that specializes in the development of psychotropic drugs. Products in their current development pipeline include Travivo™ and FKB01MD for major depression, Travivo™ and FKW00GA for generalized anxiety disorder, Travivo™ for hypoactive sexual desire disorder, FKF02SC for schizophrenia, and FKK01PD for parkinson's disease.
The company has also conducted clinical studies on a gepirone extended release formulation for major depression.